EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment

Sanja Glisic iD, Kristina Stevanovic iD, Andrej Perdih iD, Natalya Bukreyeva, Junki Maruyama iD, Vladimir Perovic iD, Sergi López-Serrano iD, Ayub Darji, Draginja Radosevic, Milan Sencanski iD, Veljko Veljkovic, Bruno Botta iD und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26135962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sanja Glisic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences VINCA, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Cyproheptadine, Antiviral Agents, Influenza A virus. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia, NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseas-es, EU’s NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza is still a chronic global health threat, inducing a sustained search for effective antiviral therapeutics. Computational methods have played a pivotal role in developing small molecule therapeutics. In this study, we applied a combined in silico and in vitro approach to explore the potential anti-influenza activity of cyproheptadine, a clinically used histamine H1 receptor antagonist. Virtual screening based on the average quasivalence number (AQVN) and electron–ion interaction potential (EIIP) descriptors suggests similarities between cyproheptadine and several established anti-influenza agents. The subsequent ligand-based pharmacophore screening of a focused H1 antagonist library was aligned with the bioinformatics prediction, and further experimental in vitro evaluation of cyproheptadine demonstrated its anti-influenza activity. These findings provide proof of concept for cyproheptadine’s in silico-predicted antiviral potential and underscore the value of integrating computational predictions with experimental validation. The results of the current study provide a preliminary proof of concept for the predicted anti-influenza potential based on computational analysis and emphasize the utility of integrating in silico screening with experimental validation in the early stages of drug repurposing efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyproheptadineAntiviral AgentsInfluenza A virusHumansComputer SimulationMolecular Docking SimulationInfluenza, HumanAnimalsComputational BiologyDogs

Stichwörter der Autor:innen

antiviralcyproheptadinedrug resistanceinfluenzavirtual screening

Substanzen

CyproheptadineAntiviral Agents

Autor:innen und Institutionen

  • Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences VINCA, University of Belgrade, 11000 Belgrade, Serbia.
  • Theory Department, National Institute of Chemistry, 1000 Ljubljana, Slovenia.
  • Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77550, USA.
  • Infection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), 08003 Barcelona, Spain.

ORCID-Profile: Sanja Glisic, Kristina Stevanovic, Andrej Perdih, Junki Maruyama, Vladimir Perovic, Sergi López-Serrano, Milan Sencanski, Bruno Botta, Mattia Mori

Förderung

  • Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseas-es
  • EU’s NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases

Zitieren

APA

Glisic, S., Stevanovic, K., Perdih, A., Bukreyeva, N., Maruyama, J., Perovic, V., López-Serrano, S., Darji, A., Radosevic, D., Sencanski, M., Veljkovic, V., Botta, B., Mori, M., & Paessler, S. (2025). Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135962

Vancouver

Glisic S, Stevanovic K, Perdih A, Bukreyeva N, Maruyama J, Perovic V, et al. Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135962

BibTeX
@article{Glisic2025,
  author = {Glisic, Sanja and Stevanovic, Kristina and Perdih, Andrej and Bukreyeva, Natalya and Maruyama, Junki and Perovic, Vladimir and López-Serrano, Sergi and Darji, Ayub and Radosevic, Draginja and Sencanski, Milan and Veljkovic, Veljko and Botta, Bruno and Mori, Mattia and Paessler, Slobodan},
  title = {Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26135962}
}
Kostenlos starten →